Terminology Service for NFDI4Health
MART-1 Fowlpox Vaccine
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2776
A synthetic cancer vaccine derived from a melanoma-associated antigen, MART-1. Antigenic peptides derived from MART-1 are recognized by CD8+ T lymphocytes and have been used to immunize patients with advanced melanomas; prolonged immunization may result in a reduction in tumor size. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it does not multiply in human tissues. (NCI04) [ ]
Term info
Label
MART-1 Fowlpox Vaccine
Synonyms
- MART-1 Fowlpox Vaccine
Legacy Concept Name
MART-1_Fowlpox_Vaccine
NSC Code
673926
Preferred Name
MART-1 Fowlpox Vaccine
Semantic Type
Pharmacologic Substance, Immunologic Factor
UMLS CUI
C1518110
code
C2776
Term relations
Subclass of:
- Fowlpox Virus Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Regulation Process
- Chemical_Or_Drug_Affects_Abnormal_Cell some Melanoma Cell
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation